168a. Decreasing the Risk of Antibacterial Drug Development through Pharmacokinetics/Pharmacodynamics
Monday, October 27, 2008: 8:30 AM-10:30 AM
Room: Constitution E (Grand Hyatt)

Conveners:  David Melnick, MD, Astra Zeneca Pharmaceuticals and Sujata Bhavnani, PharmD, Institute for Clinical Pharmacodynamics at Ordway Research Inst.

CME Credits:

ACPE Credits: 2

ACPE Number: 388-999-08-134-L04-P

See more of: Symposium